This inventor holds 44 USPTO granted patents and 14 published patent applications, plus 4 CIPO patents and 14 EPO patents, primarily in Nucleic Acid Amplification. Top assignees: Rubicon Genomics, Inc., Swift Biosciences, Inc., Takara Bio USA, Inc.. Active years: 2001-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2001-2025
Areas of Expertise:
Title: Innovations by Vladimir L Makarov: A Pioneer in Nucleic Acid Research
Introduction: Vladimir L Makarov, based in Ann Arbor, MI, is an accomplished inventor with an impressive portfolio of 42 patents. His contributions to the field of nucleic acid research have made significant impacts, particularly in the realms of substrate polynucleotides and next-generation sequencing (NGS) methodologies.
Latest Patents: Two of Makarov's latest patents exhibit his innovative approach to nucleic acid manipulation. The first patent, titled "Methods and compositions for size-controlled homopolymer tailing of substrate polynucleotides by a nucleic acid polymerase," focuses on methods for adding tails of specific lengths to substrate polynucleotides. It also details techniques for immobilizing these tailed substrates onto solid supports. The second patent addresses "Normalization of NGS library concentration." This invention provides solutions to a significant bottleneck in the NGS workflow by enabling the accurate quantification of libraries for more efficient pooling and loading onto sequencing instruments.
Career Highlights: Throughout his career, Makarov has demonstrated excellence in research and innovation. He has worked with notable companies such as Rubicon Genomics, Inc. and Swift Biosciences, Inc., where he contributed to advancements in genomic technologies that enhance research capabilities.
Collaborations: Makarov has collaborated with fellow innovators, including Emmanuel Kamberov and Brendan J Tarrier. Their collective efforts have further advanced the understanding and application of nucleic acid technologies.
Conclusion: Vladimir L Makarov stands out as a key figure in the field of innovations related to nucleic acids. His ongoing efforts and significant contributions continue to push the boundaries of research and technology, inspiring future advancements in genetic and genomic sciences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile